On air · 2 of 3 networks
Delve Bio
- delve.bio
- Healthcare & Life Sciences
- US
- 41 employees
Delve Bio’s ads on LinkedIn, Meta and Google, recorded by adsrunning. Browse the latest here for free. Sign up free to see all 32. Watch Delve Bio with Starter to get each new one in your feed.
Watchlist with Starter · $49/mo
| Network | Status | Live ads | Nov 2025LinkedIn activity · 52 weeksOct 2026 | Checked | Next step |
|---|---|---|---|---|---|
| Running | 32 | Checked 30 Oct 2026 | See all 32 ads → | ||
| Meta | Not checked | — | |||
| Running | 21 | Ads on the Google Ads Transparency Center | Checked 27 Oct 2026 | Collect them with the API → |
Delve Bio has 32 live LinkedIn ads. We recorded 21 Google ads on 27 Oct 2026.
Latest ads
- LINKEDIN · IMAGERecorded 15 Sept 2026
Learn why early use of metagenomic CSF testing may be beneficial for immunocompromised patients in the webinar led by Penn Medicine's Dr. Kyle Rodino.
- LINKEDIN · IMAGERecorded 15 Sept 2026
Join Penn Medicine's Dr. Kyle Rodino to explore the impact of early implementation of metagenomic NGS for pathogen detection in cerebrospinal fluid.
- LINKEDIN · IMAGERecorded 15 Sept 2026
Join us for the webinar: Dr. Kyle Rodino of Penn Medicine discusses how early adoption of metagenomic NGS for cerebrospinal fluid can improve patient care.
- LINKEDIN · EVENTRecorded 15 Sept 2026
In this LinkedIn Live session, Dr. Kyle Rodino of Penn Medicine, University of Pennsylvania Health System presents compelling evidence on how early adoption of Delve Bio's metagenomic next-generation sequencing (mNGS) for cerebrospinal fluid (CSF) can improve patient care guided through diagnostic stewardship. Through real-world case studies, he demonstrates that implementing mNGS in the diagnostic workflow can accelerate the detection of complex pathogens, reduce unnecessary testing, and shorten hospital stays for critically ill patients.
- LINKEDIN · IMAGERecorded 15 Sept 2026
Join UCSF’s Dr. Charles Chiu to explore Delve Detect for agnostic, rapid pathogen ID in cerebrospinal fluid using NGS.
- LINKEDIN · IMAGERecorded 15 Sept 2026
Dr. Charles Chiu discusses Delve Detect: unbiased pathogen detection in CSF using metagenomic next-generation sequencing.
6 of 32 adsSign up to see every Delve Bio ad, filter by format and date, and get alerts on new ones.
See all 32 adsWatch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.